Ichthyol rectal suppositories 0.2 g No. 10

Instructions for Ichthyol rectal suppositories 0.2 g No. 10

Composition

active ingredient: ichthyol;

1 suppository contains ichthyol 200 mg;

excipient: solid fat.

Dosage form

Rectal suppositories.

Main physicochemical properties: dark brown suppositories with an ichthyol odor. A barely noticeable white coating on the surface of the suppository is allowed.

Pharmacotherapeutic group

Antihemorrhoidal agents for topical use. ATX code C05A X.

Pharmacological properties

Pharmacodynamics

Ichthyol contains approximately 10.5% sulfur in the form of organic compounds, which is responsible for its antiseptic, anti-inflammatory and analgesic properties. The anti-inflammatory effect is associated with the inhibition of the release of inflammatory mediators. When used rectally, the drug has an irritating effect on the mucous membrane of the rectum, which reflexively increases blood circulation in the pelvic organs, which helps eliminate inflammation in the prostate gland in men; in the ovaries, fallopian tubes, uterus in women.

Pharmacokinetics

When administered rectally, it is well absorbed in the rectum. It is excreted in the feces.

Indication

In the complex treatment of pelvic inflammatory diseases (metritis, parametritis, salpingitis, adnexitis, oophoritis), chronic nonspecific prostatitis and hemorrhoids.

Contraindication

Hypersensitivity to any of the components of the drug.

Interaction with other medicinal products and other types of interactions

The interaction of the drug in the form of suppositories with other drugs has not been described.

Ability to influence reaction speed when driving vehicles or other mechanisms

Data is missing.

Use during pregnancy or breastfeeding

The drug can be used in cases where the expected benefit to the mother outweighs the potential risk to the fetus (child).

Method of administration and doses

For adults. Enter rectally 1 suppository 1–2 times a day after a cleansing enema or after a normal act of defecation. The duration of the course of treatment is determined by the doctor individually. Usually the course of treatment is 7–14 days. If the disease relapses, repeat the course of treatment.

Children

Do not use on children.

Overdose

Cases of overdose have not been described.

Adverse reactions

Allergic reactions are possible, including itching, skin rashes, swelling, redness at the site of drug injection.

Expiration date

2 years.

Storage conditions

In original packaging at a temperature not exceeding 15 °C.

Keep out of reach of children.

Packaging

5 suppositories in a strip. 2 strips in a cardboard pack.

Vacation category

Without a prescription.

Producer

PJSC "Monpharm".

Location of the manufacturer and its business address

Ukraine, 19100, Cherkasy region, Monastyryshche, Zavodska st., 8.